Grifols (RTP)
Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology.
Company Location
4101 Research Commons, 79 T.W. Alexander Drive
Research Triangle Park
NC
27709
P.O. Box 110526
Research Triangle Park
NC
27709
Phone
County
Region
Company Details
Company type
Year founded
1909
Employment range in NC
US headquarters
California
Global headquarters
Spain
Primary site activity
Potential end market(s)
Products on market
Gamunex-C, PROLASTIN-C, GamaSTAN, HyperHEP B, HyperRHO, HyperRAB, HyperTET, Plasmanate, Thrombate III, Albutein, Alphanate, AlphaNine, TdVax
Products under development
Pipeline development areas include: Thrombolytics, Pulmonary, Immunology, Hematology, Neurology